Altered biodistribution of [ 68 Ga]Ga-DOTA-TOC during somatostatin analogue treatment.
Tineke van de WeijerF BemerJudith De Vos-GeelenBregtje C M HermansCristina MiteaJochem A J van der PolT LodewickJoachim E WildbergerFelix Manuel MottaghyPublished in: European journal of nuclear medicine and molecular imaging (2024)
Ga]Ga-DOTA-TOC PET should be done with caution as the altered biodistribution of the tracer after SSA treatment should be taken into account. We recommend not to perform a scan within the first 5 days after the injection of lanreotide.